Quarterly results

Q4 2025

Read Q4 2025 report

Philips delivers full year 2025 with growth acceleration, strong margin expansion and solid cash flow; announces 2026-2028 targets at Capital Markets Day

Q4 2025 at a glance

Key figures

Sales
5.1 billion EUR
Sales

Group sales in Q4 2025 amounted to EUR 5.1 billion.

Read more
Comparable sales growth
7%
Comparable sales growth

Comparable sales increased by 7%, driven by growth across all segments.

Read more
Adjusted EBITA margin
15.1%
Adjusted EBITA margin

Adjusted EBITA increased to EUR 770 million and the margin improved to 15.1%.

Read more
Lives improved
2 billion
Lives improved

In Q4 2025, we improved the lives of 1.96 billion people.

Read more
Circular revenues
27.6%
Circular revenues

Circular revenues, which is our overarching circularity metric related to products, services and solutions across our Businesses.

Read more
Employees
~65,000
Employees

The total number of Philips employees (in full-time equivalents, excluding third-party workers) was 64,817 at the end of Q4 2025.

Read more
Highlights

The innovation that Philips brings to healthcare – often as part of long-term partnerships – is critical, making care delivery more convenient and sustainable.

Breakthrough innovations

At RSNA, Philips presented world-first innovations, including Philips Verida, the world’s first detector-based Spectral CT fully powered by AI, and the next generation of Philips Vue PACS with a zero-footprint, web-based diagnostic viewer.

Discover more

Innovating in personal care

At the China International Import Expo, Philips revealed new oral care, grooming, and haircare innovations, including Sonicare Prestige 9900 and Norelco i9000 Prestige, reinforcing our commitment to meaningful, locally relevant innovation in China.

Discover more

Advancing cardiac solutions

Philips signed in December 2025 and completed in January 2026 the acquisition of SpectraWAVE, delivering the most advanced and complete portfolio for coronary interventional procedures in the industry.

Discover more

Supporting people and the planet

Recently, our science-based net-zero target was validated by the Science Based Targets initiative. We aim to achieve net-zero greenhouse gas emissions across our value chain by 2045. We believe everyone in the healthcare ecosystem can help advance net-zero goals, and we’ve learned some lessons on our journey so far.

Discover more
Purpose

In Q4, we improved the lives of 1.96 billion people

At Philips, we are striving to make the world healthier and more sustainable through innovation, with the goal of improving the lives of 2.5 billion people a year by 2030. This includes improving access to care in underserved communities for 400 million people a year.

To ensure we remain on track to achieve our goals, we have developed a model, audited externally, that tells us how many lives have been improved by our products and solutions in a given year.

Discover more
Downloads

Q4 results

Download all
Q4 & FY 2025 report
854 KB
Q4 & FY 2025 results presentation
1 MB
Q4 & FY 2025 webcast
Q4 & FY 2025 webcast transcript
169 KB